# CETRORELIX ACETATE
> **ANDA215737** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2022-08-12
## Drug
- **FDA Application Number:** ANDA215737
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CETRORELIX ACETATE
- **Generic name:** CETRORELIX ACETATE
- **Active ingredients:** CETRORELIX ACETATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-08-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215737)
---
*MORVS · CC0 1.0*